Wells Fargo analyst Dori Kesten downgrades Apple Hospitality REIT (NYSE:APLE) from Equal-Weight to Underweight.
Ocuphire Presenting New Data And Updates On APX3330 And Nyxol Clinical Programs At Virtual Investor R&D Day
New data support Phase 3 development of Nyxol alone as a durable single eye drop for the potential treatment of Presbyopia
First update on recruitment in APX3330 ZETA-1 Phase 2b trial: ~70% patients enrolled
New masked
